The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality improvement initiative leveraging tumor sequencing results to increase genetics referrals.
 
Michelle F. Jacobs
No Relationships to Disclose
 
Elizabeth K. Spranger
No Relationships to Disclose
 
Rashmi Chugh
Consulting or Advisory Role - Deciphera; InhibRx; Jazz Pharmaceuticals; SpringWorks Therapeutics
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Cogent Biosciences (Inst); Cornerstone Pharmaceuticals (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Janssen (Inst); Kronos Bio (Inst); Pfizer (Inst); PTC Therapeutics (Inst); Qilu Puget Sound Biotherapeutics (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer
 
Erin Frances Cobain
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca/Daiichi Sankyo; Athenex; Ayala Pharmaceuticals; bioTheranostics; Immunomedics
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
John C. Krauss
Research Funding - ACCRU (Inst); Alliance for Clinical Trials in Oncology (Inst); Alliance for Clinical Trials in Oncology (Inst); Alliance for Clinical Trials in Oncology (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb/Medarex (Inst); Cardiff Oncology; Daiichi Sankyo/Arqule (Inst); Exelixis (Inst); Hutchison MediPharma (Inst); Ignyta (Inst); Isofol Medical (Inst); Janssen Oncology (Inst); Novartis (Inst); NSABP FOUNDATION (Inst); NSABP Foundation (Inst); Pfizer (Inst); Tempest Therapeutics (Inst)
 
Denise Leung
Consulting or Advisory Role - SERVIER
 
Zachery R. Reichert
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst)
 
Vaibhav Sahai
Consulting or Advisory Role - AstraZeneca; Autem Medical; Delcath Systems; Histosonics; Incyte; Ipsen; Rafael Pharmaceuticals; SERVIER; Taiho Oncology
Research Funding - Actuate Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Esanik (Inst); Exelixis (Inst); FibroGen (Inst); Ipsen (Inst); MedImmune (Inst); Pancreatic Cancer Action Network (Inst); Rafael Pharmaceuticals (Inst); Relay Therapeutics (Inst); Relay Therapeutics (Inst); Repare Therapeutics (Inst); SERVIER (Inst); Syros Pharmaceuticals (Inst); TransThera Biosciences (Inst)
Travel, Accommodations, Expenses - ASCO; Lynx Group
Other Relationship - Rafael Pharmaceuticals (Inst)
 
Scott Schuetze
Research Funding - Adaptimmune (Inst); Amgen (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Rain Therapeutics (Inst); Shanghai Pharma (Inst); TRACON Pharma (Inst)
 
Julie Wright Nunes
Leadership - American Kidney Fund-travel reimbursement
Travel, Accommodations, Expenses - American Kidney Fund